Founded in June 1991, H Jules and Company Limited has evolved from a trader of Active Pharmaceutical Ingredients (APIs) and Excipients to a global distributor with a focus on specialized small dosage formulations such as tablets, powders, capsules, and multi-particulates (pellets), all designed for sustained and controlled release.

We are recognized for our expertise in supplying APIs and Excipients for a variety of applications, including Oral Solid Dosage forms, Cosmetics, and both Liquid and Dry Injections. Our product range extends to Direct Compression (DC) Granules for Tablets, meeting the needs of a diverse clientele across Algeria, China, Egypt, Singapore, Syria, and Latin America.

Our offerings include a wide spectrum of APIs and Excipients for therapeutic categories such as Analgesics, Amino Acids, Antibiotics, Antibacterials, Anticoagulants, Anti-inflammatories, Antimalarials, Antiemetics, and Cardiovascular treatments. We also cater to the Central Nervous System (CNS) and provide Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Our commitment to quality and innovation has established us as a trusted partner in both domestic and international markets.

In 2019, we proudly established a new Polymer Division, marking our foray into the production of pharmaceutical-grade polymers. This division is dedicated to manufacturing Methacrylic Acid and Methyl Methacrylate Copolymer (1:1) NF, commercially known as Targetcoat. This expansion reflects our continuous pursuit of diversification and excellence in the pharmaceutical industry.